The rare autoimmune disease compromises the central nervous system.
{iframe}https://www.bizjournals.com/washington/news/2019/08/27/viela-bio-clears-another-hurdle-to-get-rare.html{/iframe}
Viela Bio clears another hurdle to get rare disease drug to market – Washington Business Journal
The rare autoimmune disease compromises the central nervous system.
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.